TrialAdvances in therapy2018

A Single-Dose, Crossover-Design Bioequivalence Study Comparing Two Nicotine Gum Formulations in Healthy Subjects.

Daniel DuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.